| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.093 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |